CRL logo

CRL Charles River Laboratories International, Inc.

New York Stock Exchange · Medical - Diagnostics & Research · Healthcare

$290.19
+3.36 (+1.17%)

Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, a…

Market Cap: $13.98Bwww.criver.com

Price

$290.19+24.23%
$218.70$245.33$271.95$298.58
Jul 9Oct 2

Social Signal Score

56
5d
57
8 mentions
+1.2%
30d
57
49 mentions
+0.6%
60d
55
91 mentions
+8.5%
90d
55
91 mentions
+29.6%
news: 15 · 4chan: 11 · rss: 64 · podcast: 1

Analyst Ratings

37 analysts
Buyconsensus
Strong Buy 1Buy 26Hold 10Sell 0Strong Sell 0
Avg price target$305.5+5.3%
Low $219Median $321High $357
Current Consensus

52-week range

$149.93$298.58
Last close
$290.19
Off 52w high
-2.8%
200-day average
$209.97
vs 200-day
+38.2%

Revenue

$1.00B+135.85%
$425.72M$650.43M$875.14M$1.10B
Sep 2016Jun 2026

Analyst Estimates

FY2025
$10.24
$10.18–$10.28
13 analysts
FY2026
$11.35+11% YoY
$11.16–$11.45
10 analysts
FY2027
$12.78+13% YoY
$12.04–$13.05
10 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Birgit Girshick
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
19,000
Beta
1.41
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
2.60
www.criver.com